Board meeting on 5 November 2026 to consider unaudited Q2 and H1 results
Hester Biosciences has informed BSE and NSE that its Board of Directors will meet on Thursday, 5 November 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Thursday, 5 November 2026
- Period Covered
- quarter and six months ended 30 September 2026
- Agenda Item
- unaudited standalone and consolidated financial results
What the company has told the exchanges
Hester Biosciences has informed BSE (scrip code 524669) and NSE (symbol HESTERBIO) that a meeting of its Board of Directors is scheduled to be held on Thursday, 5 November 2026.
The stated purpose of the meeting is, among other things, to consider the unaudited standalone and consolidated financial results of the company for the quarter and six months period ended 30 September 2026.
The intimation is signed by Vinod Mali, Company Secretary and Compliance Officer.
Why this matters to a shareholder
- This is a date announcement, not the results themselves. It tells you when the numbers for the September quarter will be taken up by the Board.
- Two sets of results are mentioned: standalone (the company on its own) and consolidated (the company together with its subsidiaries). Reading both together shows how much of the performance comes from the core business and how much from group entities.
- The period covered is both the quarter and the six months ended 30 September 2026, so the update covers the second quarter as well as the first half of the financial year.
How to read this kind of notice
A board meeting intimation is a routine calendar item for a listed company. It does not contain any financial performance information, guidance or decision on dividends or other corporate actions. Its usefulness is in flagging the date on which the company's September-quarter accounts will be placed before the Board.
What to look for when the results are published
- Standalone and consolidated revenue and profit for the quarter, and how they compare with the same period a year earlier.
- The half-year picture, since seasonal or one-off items in a single quarter can look larger or smaller when seen over six months.
- Any commentary the company gives alongside the numbers on its business segments.
In short: a scheduling notice, with the substantive information still to come on the meeting date.
Also from Hester Biosciences
Hester Biosciences schedules Q2 & H1 FY27 earnings conference call on 5 November 2026 at 2:00 p.m. IST
28 Oct 2026
Independent Director Ameetkumar Desai completes tenure; decides not to seek second term
27 Oct 2026
Board approves up to INR 10.50 million capital contribution for 26% of Slyce Agri World LLP
6 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.